MA23967A1 - Nouveaux derives de piperidine, leur fabrication et leur utilisation comme medicaments - Google Patents

Nouveaux derives de piperidine, leur fabrication et leur utilisation comme medicaments

Info

Publication number: MA23967A1
Authority: MA; Morocco
Prior art keywords: manufacture; piperidine derivatives; medicines; novel piperidine; novel
Prior art date: 1995-09-07

Application number

MA24347A

Other languages

English (en)

Inventor

Muller Marcel

Hirth Georges

Guller Rolf

Oefner Christian

Stadler Heinz

Breu Volker

Binggeli Alfred

Fischli Walter

Vieira Eric

Wosti Wolfgang

Bur Daniel

Wilheim Maurice

Marki Hans-Peter

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-07

Filing date

1996-09-06

Publication date

1997-04-01

1996-09-06 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1997-04-01 Publication of MA23967A1 publication Critical patent/MA23967A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

MA24347A 1995-09-07 1996-09-06 Nouveaux derives de piperidine, leur fabrication et leur utilisation comme medicaments MA23967A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH254895		1995-09-07
CH187696		1996-07-26

Publications (1)

Publication Number	Publication Date
MA23967A1 true MA23967A1 (fr)	1997-04-01

Family

ID=25688898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24347A MA23967A1 (fr)	1995-09-07	1996-09-06	Nouveaux derives de piperidine, leur fabrication et leur utilisation comme medicaments

Country Status (27)

Country	Link
US (2)	US6051712A (fr)
EP (1)	EP0863875B1 (fr)
JP (1)	JP3648251B2 (fr)
KR (1)	KR100384979B1 (fr)
CN (1)	CN1256326C (fr)
AT (1)	ATE242213T1 (fr)
BR (1)	BR9610385A (fr)
CA (1)	CA2230931C (fr)
CY (1)	CY2488B1 (fr)
CZ (1)	CZ292327B6 (fr)
DE (1)	DE59610509D1 (fr)
DK (1)	DK0863875T3 (fr)
ES (1)	ES2201192T3 (fr)
HK (1)	HK1016177A1 (fr)
HU (1)	HUP9900926A3 (fr)
IL (1)	IL123293A (fr)
MA (1)	MA23967A1 (fr)
MY (1)	MY121967A (fr)
NO (1)	NO310069B1 (fr)
NZ (1)	NZ315677A (fr)
PL (1)	PL193686B1 (fr)
PT (1)	PT863875E (fr)
RU (1)	RU2167865C2 (fr)
SA (1)	SA96170317B1 (fr)
TR (1)	TR199800409T1 (fr)
TW (1)	TW474932B (fr)
WO (1)	WO1997009311A1 (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU221921B1 (hu)	1996-07-08	2003-02-28	Richter Gedeon Vegyészeti Gyár Rt.	N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
AU7206398A (en)	1997-05-14	1998-12-08	Neurosearch A/S	Piperidine derivatives as neurotransmitter re-uptake inhibitors
JP2002514222A (ja)	1997-05-29	2002-05-14	スミスクライン・ビーチャム・コーポレイション	新規方法
WO1999012532A2 (fr) *	1997-09-08	1999-03-18	F.Hoffmann-La Roche Ag	Derives de piperidine contre la malaria
AR015269A1 (es)	1998-04-10	2001-04-18	Japan Tobacco Inc	Compuesto amidinico y composicion farmaceutica, inhibidor de la coagulacion sanguinea e inhibidor del factor xa que lo comprenden
US6268499B1 (en) *	1998-08-10	2001-07-31	Hoffman-La Roche Inc.	Process and intermediates for preparation of substituted piperidine-epoxides
US6274735B1 (en)	1998-08-10	2001-08-14	Hoffmann-La Roche Inc.	Process and intermediates for preparation of substituted piperidines
WO2000063173A1 (fr) *	1999-04-14	2000-10-26	F. Hoffmann-La Roche Ag	Procede de preparation de piperidines substituees
US6197959B1 (en)	1999-04-27	2001-03-06	Hoffmann-La Roche Inc.	Piperidine derivatives
US6376672B1 (en) *	1999-04-27	2002-04-23	Hoffmann-La Roche Inc.	Naphthalenylmethoxypiperidines as renin inhibitors
IT1313702B1 (it) *	1999-08-02	2002-09-09	Chemi Spa	Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
EP1214303A1 (fr) *	1999-08-31	2002-06-19	Merck & Co., Inc.	Composes heterocycliques et procedes d'utilisation de ceux-ci
CZ20021663A3 (cs)	1999-10-15	2002-09-11	F. Hoffmann-La Roche Ag	Nové deriváty benzodiazepinu
HUP0300649A3 (en) *	2000-06-13	2003-10-28	Basf Ag	Fungicidal 5-phenyl substituted 2-(cyanoamino)pyrimidines, preparation and use thereof
WO2002076440A2 (fr) *	2001-03-23	2002-10-03	Elan Pharmaceuticals, Inc.	Methodes de traitement de la maladie d'alzheimer
CA2467749A1 (fr)	2001-11-19	2003-05-30	Elan Pharmaceuticals, Inc.	Piperidines et piperazines 3,4-disubstituees, 3,5-disubstituees et 3,4,5-substituees
CN1649870A (zh) *	2002-04-29	2005-08-03	埃科特莱茵药品有限公司	7－芳基－3,9－二氮杂双环[3.3.1]壬－6－烯衍生物及其在治疗高血压,心血管或肾疾病中作为肾素抑制剂的应用
AU2003229746A1 (en) *	2002-06-27	2004-01-19	Actelion Pharmaceuticals Ltd	Novel tetrahydropyridine derivatives as renin inhibitors
CN1964630A (zh)	2003-02-13	2007-05-16	耶希瓦大学艾伯塔·爱恩斯坦医学院	通过控制下丘脑的长链脂肪酰基－辅酶A(LC－CoA)的水平来调控食物摄取和葡萄糖产生
US20040214832A1 (en) *	2003-04-10	2004-10-28	Cuiman Cai	Piperazine derivative renin inhibitors
US20040204455A1 (en) *	2003-04-10	2004-10-14	Cody Wayne Livingston	Piperidine derivative rennin inhibitors
US20060217371A1 (en) *	2003-04-28	2006-09-28	Olivier Bezencon	Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors
CA2521932A1 (fr) *	2003-04-29	2004-11-11	Actelion Pharmaceuticals Ltd	Nouveaux derives de la 1,2,3,6-tetrahydropyridine 3,4-disubstituee
CN1780663A (zh) *	2003-04-30	2006-05-31	埃科特莱茵药品有限公司	作为肾素抑制剂的新型3－位具有杂原子的9－氮杂双环壬烯衍生物
KR20060006069A (ko) *	2003-04-30	2006-01-18	액테리온 파마슈티칼 리미티드	아자비사이클로노넨 유도체
JP2006524657A (ja) *	2003-04-30	2006-11-02	アクテリオン　ファマシューティカルズ　リミテッド	新規トロパン誘導体
RU2005137571A (ru) *	2003-05-02	2006-05-10	Актелион Фармасьютикалз Лтд. (Ch)	Новые производные диазабициклононена
DE602004021206D1 (de) *	2003-07-24	2009-07-02	Euro Celtique Sa	Zur Behandlung oder Vorbeugung von Schmerzen geeignete Heteroaryl-Tetrahydropiperidyl-Verbindungen
TW200513461A (en)	2003-10-01	2005-04-16	Speedel Experimenta Ag	Organische verbindungen
AR045950A1 (es) *	2003-10-09	2005-11-16	Speedel Experimenta Ag	Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
US20070135405A1 (en) *	2003-10-23	2007-06-14	Olivier Bezencon	Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain
KR20060120146A (ko)	2003-11-26	2006-11-24	노파르티스 아게	레닌 억제제로서의 4-페닐피페리딘 유도체
NZ549535A (en)	2004-03-17	2010-11-26	Novartis Ag	Use of aliskiren for treating renal and other disorders
JP2007223901A (ja) *	2004-03-24	2007-09-06	Takeda Chem Ind Ltd	複素環化合物およびその用途
AR053406A1 (es) *	2004-07-09	2007-05-09	Speedel Experimenta Ag	Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas
CN101010323B (zh)	2004-08-25	2010-06-16	埃科特莱茵药品有限公司	作为肾素抑制剂的双环壬烯衍生物
GB0428526D0 (en)	2004-12-30	2005-02-09	Novartis Ag	Organic compounds
GB0500784D0 (en) *	2005-01-14	2005-02-23	Novartis Ag	Organic compounds
ATE514697T1 (de) *	2005-01-28	2011-07-15	Actelion Pharmaceuticals Ltd	7-ä4-ä2-(2,6-dichloro-4- methylphenoxy)ethoxyüphenylü-3,9- diazabicycloä3.3.1ünon-6-ene-6-carbonsäure- cyclopropyl-(2,3-dimethylbenzyl)amid als renin- hemmer für die behandlung von bluthochdruck
TW200722424A (en)	2005-03-31	2007-06-16	Speedel Experimenta Ag	Substituted piperidines
EP1897879A3 (fr)	2005-03-31	2008-06-11	Speedel Experimenta AG	Pipéridines 2,4,5-substituées comme inhibiteurs de la rénine
US20090270380A1 (en) *	2005-03-31	2009-10-29	Peter Herold	3,4,5-Substituted Piperidines as Renin Inhibitors
EP1707202A1 (fr) *	2005-03-31	2006-10-04	Speedel Experimenta AG	Composes organiques
ES2352564T3 (es) *	2005-03-31	2011-02-21	Novartis Ag	Piperidinas sustituidas.
TW200833687A (en) *	2005-03-31	2008-08-16	Speedel Experimenta Ag	Substituted piperidines
GB0508992D0 (en) *	2005-05-03	2005-06-08	Novartis Ag	Organic compounds
GB0510810D0 (en) *	2005-05-26	2005-06-29	Novartis Ag	Organic compounds
GEP20115206B (en)	2005-05-27	2011-04-26	Actelion Pharmaceuticals Ltd	Novel piperidine carboxylic acid amide derivatives
WO2006131884A2 (fr) *	2005-06-07	2006-12-14	Actelion Pharmaceuticals Ltd	Nouveaux derives de thiazole
GB0514203D0 (en)	2005-07-11	2005-08-17	Novartis Ag	Organic compounds
KR101020351B1 (ko)	2005-07-29	2011-03-08	에프. 호프만-라 로슈 아게	인돌-3-일-카본일-피페리딘 및 피페라진 유도체
US20070142389A1 (en) *	2005-12-20	2007-06-21	Pfizer Inc.	Piperidine derivatives
EP2420491B1 (fr)	2005-12-30	2013-07-03	Novartis AG	Dérivés de pipéridine 3,5-substitués en tant qu'inhibiteurs de rénine
EP1816122A3 (fr) *	2006-01-19	2007-09-19	Speedel Experimenta AG	Pipéridines substituées 3,4,5 en tant que composants thérapeutiques
TW200804359A (en) *	2006-01-19	2008-01-16	Speedel Experimenta Ag	Substituted 4-phenylpiperidines
RU2425032C2 (ru)	2006-02-02	2011-07-27	Актелион Фармасьютикалз Лтд	Вторичные амины в качестве ингибиторов ренина
WO2007120523A2 (fr) *	2006-03-31	2007-10-25	Vitae Pharmaceuticals, Inc.	6-(aminoalkyl)indazoles
JP5420398B2 (ja)	2006-05-19	2014-02-19	アッヴィ・バハマズ・リミテッド	Ｃｎｓ活性縮合ビシクロ複素環置換アザ二環式アルカン誘導体
TW200815425A (en)	2006-06-08	2008-04-01	Speedel Experimenta Ag	2,5-disubstituted piperidines
CL2007002689A1 (es)	2006-09-18	2008-04-18	Vitae Pharmaceuticals Inc	Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EP2097377B1 (fr) *	2006-11-17	2010-07-07	Merck Frosst Canada Ltd.	Inhibiteurs de la rénine
US7638541B2 (en)	2006-12-28	2009-12-29	Metabolex Inc.	5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP1987834A3 (fr)	2007-02-13	2008-11-19	Speedel Experimenta AG	Pipéridines substituées en tant que composants thérapeutiques
WO2008128889A1 (fr) *	2007-04-19	2008-10-30	F. Hoffmann-La Roche Ag	Dérivés du dihydro-benzo[b][1,4]diazépine-2-one sulfamide
NZ580266A (en) *	2007-04-27	2012-03-30	Purdue Pharma Lp	Trpv1 inhibitors / antagonists and uses thereof
EP2181105B1 (fr)	2007-06-25	2015-04-29	Novartis AG	Derives de n5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide utiles comme inhibiteurs de renine
CA2693169C (fr)	2007-07-19	2016-01-12	Metabolex, Inc.	Agonistes de recepteur heterocyclique a liaison n pour le traitement du diabete et des troubles metaboliques
EP2018862A1 (fr)	2007-07-25	2009-01-28	Speedel Experimenta AG	Pipéridines substituées en tant que composants thérapeutiques
TW200927101A (en)	2007-10-18	2009-07-01	Speedel Experimenta Ag	Trisubstituted piperidines
TW200922596A (en) *	2007-10-25	2009-06-01	Speedel Experimenta Ag	4,4-disubstituted piperidines
KR20100075590A (ko) *	2007-11-02	2010-07-02	노파르티스 아게	레닌 억제제로서의 4,4-이치환된 피페리딘
TW200932241A (en)	2007-12-05	2009-08-01	Speedel Experimenta Ag	Organic compounds
WO2009106599A2 (fr) *	2008-02-29	2009-09-03	Novartis Ag	Pipéridines substituées en tant que composés thérapeutiques
KR20100134659A (ko) *	2008-03-31	2010-12-23	메타볼렉스, 인코포레이티드	옥시메틸렌 아릴 화합물 및 그것의 사용
JP4790871B2 (ja)	2008-05-05	2011-10-12	メルクフロストカナダリミテツド	レニン阻害剤としての３，４−置換ピペリジン誘導体
KR20110026481A (ko) *	2008-06-20	2011-03-15	메타볼렉스, 인코포레이티드	아릴 ｇｐｒ１１９ 작동약 및 이의 용도
JPWO2010013849A1 (ja)	2008-08-01	2012-01-12	日本ケミファ株式会社	Ｇｐｒ１１９作動薬
EP2163245A1 (fr)	2008-09-10	2010-03-17	Novartis Ag	Inhibiteurs de la rénine pour le traitement du psoriasis
JP2010090110A (ja) *	2008-09-12	2010-04-22	Sumitomo Chemical Co Ltd	Ｎ−置換−トランス−４−アジドピペリジン−３−オールの製造方法
EP2376473A4 (fr) *	2008-12-10	2012-05-02	Merck Canada Inc	Dérivés de pipéridine à substitution en 3,4 utilisés comme inhibiteurs de rénine
EP2421828A2 (fr)	2009-04-24	2012-02-29	Cadila Healthcare Limited	Derivatifs de piperidine comme inhibiteurs de rénine
WO2011030139A1 (fr)	2009-09-11	2011-03-17	Astrazeneca Ab	Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119
WO2011041154A1 (fr) *	2009-10-01	2011-04-07	Metabolex, Inc.	Sels de la tétrazol-1-yl-phénoxyméthyl-thiazol-2-yl-pipéridinyl-pyrimidine substituée
CN109674753A (zh)	2010-06-23	2019-04-26	希玛贝治疗股份有限公司	固态分散体
US20120184572A1 (en) *	2011-01-13	2012-07-19	Metabolex, Inc.	Aryl gpr119 agonists and uses thereof
KR20150055094A (ko)	2011-06-22	2015-05-20	퍼듀 퍼머 엘피	디히드록시 치환기를 포함하는 trpv1 길항제 및 그의 용도
WO2013088452A2 (fr)	2011-11-11	2013-06-20	Sun Pharma Advanced Research Company Ltd.	Dérivés de quinoléine utilisés en tant qu'inhibiteurs de la rénine
WO2013084241A1 (fr)	2011-12-09	2013-06-13	Cadila Healthcare Limited	Composés inhibiteurs de rénine
CN104370813A (zh) *	2014-10-22	2015-02-25	上海大学	异喹啉-6-甲醛的制备方法
US10292983B2 (en)	2016-08-03	2019-05-21	Cymabay Therapeutics, Inc.	Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN110041212B (zh) *	2019-05-21	2020-10-02	吉林大学	一种含氟多胺单体及其制备方法、一种聚酰亚胺及其制备方法和一种聚酰亚胺膜
CN119059990B (zh) *	2024-11-01	2025-02-07	安徽昊帆生物有限公司	1-氨基甲酸叔丁酯哌嗪的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1545792B2 (de) *	1965-02-27	1975-08-07	Bayer Ag, 5090 Leverkusen	Verfahren zur Herstellung von 4-Hydroxyplperidinen
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
IE45511B1 (en) *	1976-09-01	1982-09-08	Ciba Geigy Ag	New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
DK715988D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5272156A (en) *	1989-09-19	1993-12-21	Allergan, Inc.	Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
RU2097378C1 (ru) *	1991-03-26	1997-11-27	Ф.Хоффманн-Ля Рош Аг	ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
US5545658A (en) *	1991-03-26	1996-08-13	Hoffman-La Roche Inc.	Amino acid derivatives

1996
- 1996-08-29 WO PCT/EP1996/003803 patent/WO1997009311A1/fr active IP Right Grant
- 1996-08-29 DK DK96927715T patent/DK0863875T3/da active
- 1996-08-29 DE DE59610509T patent/DE59610509D1/de not_active Expired - Lifetime
- 1996-08-29 PL PL96325425A patent/PL193686B1/pl not_active IP Right Cessation
- 1996-08-29 AT AT96927715T patent/ATE242213T1/de active
- 1996-08-29 EP EP96927715A patent/EP0863875B1/fr not_active Expired - Lifetime
- 1996-08-29 RU RU98106388/04A patent/RU2167865C2/ru not_active IP Right Cessation
- 1996-08-29 KR KR10-1998-0701707A patent/KR100384979B1/ko not_active IP Right Cessation
- 1996-08-29 IL IL12329396A patent/IL123293A/xx not_active IP Right Cessation
- 1996-08-29 CN CNB961976748A patent/CN1256326C/zh not_active Expired - Fee Related
- 1996-08-29 ES ES96927715T patent/ES2201192T3/es not_active Expired - Lifetime
- 1996-08-29 TR TR1998/00409T patent/TR199800409T1/xx unknown
- 1996-08-29 CZ CZ1998684A patent/CZ292327B6/cs not_active IP Right Cessation
- 1996-08-29 HU HU9900926A patent/HUP9900926A3/hu unknown
- 1996-08-29 PT PT96927715T patent/PT863875E/pt unknown
- 1996-08-29 CA CA002230931A patent/CA2230931C/fr not_active Expired - Fee Related
- 1996-08-29 NZ NZ315677A patent/NZ315677A/en not_active IP Right Cessation
- 1996-08-29 JP JP51083797A patent/JP3648251B2/ja not_active Expired - Fee Related
- 1996-08-29 BR BR9610385A patent/BR9610385A/pt not_active IP Right Cessation
- 1996-09-02 TW TW085110684A patent/TW474932B/zh not_active IP Right Cessation
- 1996-09-05 MY MYPI96003683A patent/MY121967A/en unknown
- 1996-09-06 MA MA24347A patent/MA23967A1/fr unknown
- 1996-09-24 SA SA96170317A patent/SA96170317B1/ar unknown
1998
- 1998-03-05 NO NO980954A patent/NO310069B1/no not_active IP Right Cessation
1999
- 1999-02-22 US US09/255,185 patent/US6051712A/en not_active Expired - Lifetime
- 1999-03-30 HK HK99101299A patent/HK1016177A1/xx not_active IP Right Cessation
- 1999-12-07 US US09/456,283 patent/US6150526A/en not_active Expired - Lifetime
2004
- 2004-12-03 CY CY0400088A patent/CY2488B1/xx unknown

Also Published As

Publication number	Publication date
BR9610385A (pt)	1999-07-06
CZ68498A3 (cs)	1998-10-14
ATE242213T1 (de)	2003-06-15
TR199800409T1 (xx)	1998-05-21
AU6743296A (en)	1997-03-27
US6051712A (en)	2000-04-18
ES2201192T3 (es)	2004-03-16
HUP9900926A2 (hu)	1999-09-28
MY121967A (en)	2006-03-31
CN1256326C (zh)	2006-05-17
NO980954D0 (no)	1998-03-05
PL193686B1 (pl)	2007-03-30
SA96170317B1 (ar)	2006-05-13
TW474932B (en)	2002-02-01
IL123293A0 (en)	1998-09-24
PT863875E (pt)	2003-10-31
EP0863875A1 (fr)	1998-09-16
CY2488B1 (en)	2005-06-03
RU2167865C2 (ru)	2001-05-27
NO980954L (no)	1998-04-28
AU708616B2 (en)	1999-08-05
JP3648251B2 (ja)	2005-05-18
KR19990044459A (ko)	1999-06-25
EP0863875B1 (fr)	2003-06-04
KR100384979B1 (ko)	2003-10-17
DK0863875T3 (da)	2003-12-01
CN1202152A (zh)	1998-12-16
NZ315677A (en)	2000-02-28
HUP9900926A3 (en)	2002-12-28
US6150526A (en)	2000-11-21
DE59610509D1 (de)	2003-07-10
CA2230931C (fr)	2009-05-19
WO1997009311A1 (fr)	1997-03-13
NO310069B1 (no)	2001-05-14
MX9801814A (es)	1998-08-30
CA2230931A1 (fr)	1997-03-13
JPH11500447A (ja)	1999-01-12
HK1016177A1 (en)	1999-10-29
CZ292327B6 (cs)	2003-09-17
PL325425A1 (en)	1998-07-20
IL123293A (en)	2003-06-24

Publication	Publication Date	Title
MA23967A1 (fr)	1997-04-01	Nouveaux derives de piperidine, leur fabrication et leur utilisation comme medicaments
NL350077I2 (nl)	2017-07-11	Cyprosulfamide
ATE233274T1 (de)	2003-03-15	Oxyiminopregnancarbolactone
TR199902622T2 (xx)	2000-05-22	Enflamatuvar hastal�klar�n tedavisinde faydal� ikameli imidazoller.
HUP9903741A2 (hu)	2000-04-28	Asztmaellenes, allergiaellenes, immunvisszaszorító és/vagy immunmoduláló hatású N-helyettesített indol-3-glioxilamidok
DE69608916D1 (de)	2000-07-20	Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen
ID21235A (id)	1999-05-06	Produksi para-xylen terselektif oleh metilasi toluen
TR199800011T1 (xx)	1998-04-21	Benzo$g] kuinolin t�revleri
BR9610277A (pt)	1999-07-06	Derivados de piperazino como antagonistas de neurowuinina
CY1107494T1 (el)	2013-03-13	Υποκατεστημενα παραγωγα πυριδυλμεθυλπιπepαζινης και πιπepιδινης, η παρασκευη τους και η χρηση τους για θepαπεια νοσων του κεντρικου νευρικου συστηματος (κνς)
ES2107284T3 (es)	1997-11-16	Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
PT736029E (pt)	2006-05-31	Sulfamatos de pseudofructopiranose anticonvulsivos
ATE207076T1 (de)	2001-11-15	Ara-c derivate
DE69626462T2 (de)	2004-01-15	Herstellung von Gas
DK0852580T3 (da)	2000-11-20	Fremgangsmåde til fremstilling af dihydroxypyrimidin-derivater
ATE197706T1 (de)	2000-12-15	Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
DE69602903D1 (de)	1999-07-22	Herstellung von Glaszusammensetzungen
TR199701298T1 (xx)	1998-02-21	Tetralinler.
TR199801485T2 (xx)	1998-10-21	Yeni 2,3 benzodiyazepin t�revleri, bu t�revlerin �retimi ve ila� olarak kullan�m�.
IT1241988B (it)	1994-02-02	2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
ATE213236T1 (de)	2002-02-15	Substituierte benzyloxyimino-verbindungen
DE69811382D1 (de)	2003-03-20	Carbapenemderivate und herstellungsverfahren dafür
ATE183502T1 (de)	1999-09-15	Octahydro-2-naphthalincarbonsäure-derivate, ihre herstellung und verwendung
TR199800904T2 (xx)	1998-08-21	Yeni kinoksalindiyon t�revleri'nin �retimi ve ila�larda kullan�m�
YU37902A (sh)	2005-07-19	Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3- benzazocini i njihova primena kao lekova